Global ECM-derived Biomaterials Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI09244836

Publication Date:

September 27, 2024

Pages:

132

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

Extracellular matrix (ECM)-derived biomaterials are biological scaffolds created from the ECM of tissues, providing structural and biochemical support for cells. The ECM is a complex network composed of proteins, glycoproteins, and other molecules that form a supportive environment for cell attachment, growth, and differentiation. ECM-derived biomaterials are produced by decellularizing tissues to remove cellular components while preserving the ECM structure. These biomaterials are used in tissue engineering and regenerative medicine because they mimic the natural environment of tissues, promoting tissue repair and regeneration. They have been applied in a variety of medical fields, including wound healing, organ repair, and reconstructive surgery, due to their ability to support cell proliferation and integration into host tissues鈥�.
The global ECM-derived Biomaterials market size is projected to grow from US$ 38.7 million in 2024 to US$ 61.4 million in 2030; it is expected to grow at a CAGR of 8.0% from 2024 to 2030.
The 鈥淓CM-derived Biomaterials Industry Forecast鈥� looks at past sales and reviews total world ECM-derived Biomaterials sales in 2022, providing a comprehensive analysis by region and market sector of projected ECM-derived Biomaterials sales for 2023 through 2029. With ECM-derived Biomaterials sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world ECM-derived Biomaterials industry.
This Insight Report provides a comprehensive analysis of the global ECM-derived Biomaterials landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on ECM-derived Biomaterials portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global ECM-derived Biomaterials market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for ECM-derived Biomaterials and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global ECM-derived Biomaterials.
United States market for ECM-derived Biomaterials is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for ECM-derived Biomaterials is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for ECM-derived Biomaterials is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key ECM-derived Biomaterials players cover Merck, Smith&Nephew, DSM Biomedical, Corning, Thermo Fisher, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of ECM-derived Biomaterials market by product type, application, key players and key regions and countries.
Segmentation by Type:
Animal-derived EMC
Human-derived EMC
Synthetic EMC
Segmentation by Application:
Biopharmaceuticals
Clinical Medicine
Academic Research
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Segmentation by Type:
Animal-derived EMC
Human-derived EMC
Synthetic EMC
Segmentation by Application:
Biopharmaceuticals
Clinical Medicine
Academic Research
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Merck
Smith&Nephew
DSM Biomedical
Corning
Thermo Fisher
AMSBIO
Mimetas
FUJIFILM
CellSystems
Advanced BioMatrix
Bio-Techne
AROA Biosurgery
Integra LifeSciences
Elutia
ReproCELL
Biolamina
Tissue Regenix

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global ECM-derived Biomaterials Market Size 2019-2030
2.1.2 ECM-derived Biomaterials Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for ECM-derived Biomaterials by Country/Region, 2019, 2023 & 2030
2.2 ECM-derived Biomaterials Segment by Type
2.2.1 Animal-derived EMC
2.2.2 Human-derived EMC
2.2.3 Synthetic EMC
2.3 ECM-derived Biomaterials Market Size by Type
2.3.1 ECM-derived Biomaterials Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global ECM-derived Biomaterials Market Size Market Share by Type (2019-2024)
2.4 ECM-derived Biomaterials Segment by Application
2.4.1 Biopharmaceuticals
2.4.2 Clinical Medicine
2.4.3 Academic Research
2.4.4 Others
2.5 ECM-derived Biomaterials Market Size by Application
2.5.1 ECM-derived Biomaterials Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global ECM-derived Biomaterials Market Size Market Share by Application (2019-2024)
3 ECM-derived Biomaterials Market Size by Player
3.1 ECM-derived Biomaterials Market Size Market Share by Player
3.1.1 Global ECM-derived Biomaterials Revenue by Player (2019-2024)
3.1.2 Global ECM-derived Biomaterials Revenue Market Share by Player (2019-2024)
3.2 Global ECM-derived Biomaterials Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ECM-derived Biomaterials by Region
4.1 ECM-derived Biomaterials Market Size by Region (2019-2024)
4.2 Global ECM-derived Biomaterials Annual Revenue by Country/Region (2019-2024)
4.3 Americas ECM-derived Biomaterials Market Size Growth (2019-2024)
4.4 APAC ECM-derived Biomaterials Market Size Growth (2019-2024)
4.5 Europe ECM-derived Biomaterials Market Size Growth (2019-2024)
4.6 Middle East & Africa ECM-derived Biomaterials Market Size Growth (2019-2024)
5 Americas
5.1 Americas ECM-derived Biomaterials Market Size by Country (2019-2024)
5.2 Americas ECM-derived Biomaterials Market Size by Type (2019-2024)
5.3 Americas ECM-derived Biomaterials Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC ECM-derived Biomaterials Market Size by Region (2019-2024)
6.2 APAC ECM-derived Biomaterials Market Size by Type (2019-2024)
6.3 APAC ECM-derived Biomaterials Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe ECM-derived Biomaterials Market Size by Country (2019-2024)
7.2 Europe ECM-derived Biomaterials Market Size by Type (2019-2024)
7.3 Europe ECM-derived Biomaterials Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa ECM-derived Biomaterials by Region (2019-2024)
8.2 Middle East & Africa ECM-derived Biomaterials Market Size by Type (2019-2024)
8.3 Middle East & Africa ECM-derived Biomaterials Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global ECM-derived Biomaterials Market Forecast
10.1 Global ECM-derived Biomaterials Forecast by Region (2025-2030)
10.1.1 Global ECM-derived Biomaterials Forecast by Region (2025-2030)
10.1.2 Americas ECM-derived Biomaterials Forecast
10.1.3 APAC ECM-derived Biomaterials Forecast
10.1.4 Europe ECM-derived Biomaterials Forecast
10.1.5 Middle East & Africa ECM-derived Biomaterials Forecast
10.2 Americas ECM-derived Biomaterials Forecast by Country (2025-2030)
10.2.1 United States Market ECM-derived Biomaterials Forecast
10.2.2 Canada Market ECM-derived Biomaterials Forecast
10.2.3 Mexico Market ECM-derived Biomaterials Forecast
10.2.4 Brazil Market ECM-derived Biomaterials Forecast
10.3 APAC ECM-derived Biomaterials Forecast by Region (2025-2030)
10.3.1 China ECM-derived Biomaterials Market Forecast
10.3.2 Japan Market ECM-derived Biomaterials Forecast
10.3.3 Korea Market ECM-derived Biomaterials Forecast
10.3.4 Southeast Asia Market ECM-derived Biomaterials Forecast
10.3.5 India Market ECM-derived Biomaterials Forecast
10.3.6 Australia Market ECM-derived Biomaterials Forecast
10.4 Europe ECM-derived Biomaterials Forecast by Country (2025-2030)
10.4.1 Germany Market ECM-derived Biomaterials Forecast
10.4.2 France Market ECM-derived Biomaterials Forecast
10.4.3 UK Market ECM-derived Biomaterials Forecast
10.4.4 Italy Market ECM-derived Biomaterials Forecast
10.4.5 Russia Market ECM-derived Biomaterials Forecast
10.5 Middle East & Africa ECM-derived Biomaterials Forecast by Region (2025-2030)
10.5.1 Egypt Market ECM-derived Biomaterials Forecast
10.5.2 South Africa Market ECM-derived Biomaterials Forecast
10.5.3 Israel Market ECM-derived Biomaterials Forecast
10.5.4 Turkey Market ECM-derived Biomaterials Forecast
10.6 Global ECM-derived Biomaterials Forecast by Type (2025-2030)
10.7 Global ECM-derived Biomaterials Forecast by Application (2025-2030)
10.7.1 GCC Countries Market ECM-derived Biomaterials Forecast
11 Key Players Analysis
11.1 Merck
11.1.1 Merck Company Information
11.1.2 Merck ECM-derived Biomaterials Product Offered
11.1.3 Merck ECM-derived Biomaterials Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Merck Main Business Overview
11.1.5 Merck Latest Developments
11.2 Smith&Nephew
11.2.1 Smith&Nephew Company Information
11.2.2 Smith&Nephew ECM-derived Biomaterials Product Offered
11.2.3 Smith&Nephew ECM-derived Biomaterials Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Smith&Nephew Main Business Overview
11.2.5 Smith&Nephew Latest Developments
11.3 DSM Biomedical
11.3.1 DSM Biomedical Company Information
11.3.2 DSM Biomedical ECM-derived Biomaterials Product Offered
11.3.3 DSM Biomedical ECM-derived Biomaterials Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 DSM Biomedical Main Business Overview
11.3.5 DSM Biomedical Latest Developments
11.4 Corning
11.4.1 Corning Company Information
11.4.2 Corning ECM-derived Biomaterials Product Offered
11.4.3 Corning ECM-derived Biomaterials Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Corning Main Business Overview
11.4.5 Corning Latest Developments
11.5 Thermo Fisher
11.5.1 Thermo Fisher Company Information
11.5.2 Thermo Fisher ECM-derived Biomaterials Product Offered
11.5.3 Thermo Fisher ECM-derived Biomaterials Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Thermo Fisher Main Business Overview
11.5.5 Thermo Fisher Latest Developments
11.6 AMSBIO
11.6.1 AMSBIO Company Information
11.6.2 AMSBIO ECM-derived Biomaterials Product Offered
11.6.3 AMSBIO ECM-derived Biomaterials Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 AMSBIO Main Business Overview
11.6.5 AMSBIO Latest Developments
11.7 Mimetas
11.7.1 Mimetas Company Information
11.7.2 Mimetas ECM-derived Biomaterials Product Offered
11.7.3 Mimetas ECM-derived Biomaterials Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Mimetas Main Business Overview
11.7.5 Mimetas Latest Developments
11.8 FUJIFILM
11.8.1 FUJIFILM Company Information
11.8.2 FUJIFILM ECM-derived Biomaterials Product Offered
11.8.3 FUJIFILM ECM-derived Biomaterials Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 FUJIFILM Main Business Overview
11.8.5 FUJIFILM Latest Developments
11.9 CellSystems
11.9.1 CellSystems Company Information
11.9.2 CellSystems ECM-derived Biomaterials Product Offered
11.9.3 CellSystems ECM-derived Biomaterials Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 CellSystems Main Business Overview
11.9.5 CellSystems Latest Developments
11.10 Advanced BioMatrix
11.10.1 Advanced BioMatrix Company Information
11.10.2 Advanced BioMatrix ECM-derived Biomaterials Product Offered
11.10.3 Advanced BioMatrix ECM-derived Biomaterials Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Advanced BioMatrix Main Business Overview
11.10.5 Advanced BioMatrix Latest Developments
11.11 Bio-Techne
11.11.1 Bio-Techne Company Information
11.11.2 Bio-Techne ECM-derived Biomaterials Product Offered
11.11.3 Bio-Techne ECM-derived Biomaterials Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Bio-Techne Main Business Overview
11.11.5 Bio-Techne Latest Developments
11.12 AROA Biosurgery
11.12.1 AROA Biosurgery Company Information
11.12.2 AROA Biosurgery ECM-derived Biomaterials Product Offered
11.12.3 AROA Biosurgery ECM-derived Biomaterials Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 AROA Biosurgery Main Business Overview
11.12.5 AROA Biosurgery Latest Developments
11.13 Integra LifeSciences
11.13.1 Integra LifeSciences Company Information
11.13.2 Integra LifeSciences ECM-derived Biomaterials Product Offered
11.13.3 Integra LifeSciences ECM-derived Biomaterials Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Integra LifeSciences Main Business Overview
11.13.5 Integra LifeSciences Latest Developments
11.14 Elutia
11.14.1 Elutia Company Information
11.14.2 Elutia ECM-derived Biomaterials Product Offered
11.14.3 Elutia ECM-derived Biomaterials Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Elutia Main Business Overview
11.14.5 Elutia Latest Developments
11.15 ReproCELL
11.15.1 ReproCELL Company Information
11.15.2 ReproCELL ECM-derived Biomaterials Product Offered
11.15.3 ReproCELL ECM-derived Biomaterials Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 ReproCELL Main Business Overview
11.15.5 ReproCELL Latest Developments
11.16 Biolamina
11.16.1 Biolamina Company Information
11.16.2 Biolamina ECM-derived Biomaterials Product Offered
11.16.3 Biolamina ECM-derived Biomaterials Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 Biolamina Main Business Overview
11.16.5 Biolamina Latest Developments
11.17 Tissue Regenix
11.17.1 Tissue Regenix Company Information
11.17.2 Tissue Regenix ECM-derived Biomaterials Product Offered
11.17.3 Tissue Regenix ECM-derived Biomaterials Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 Tissue Regenix Main Business Overview
11.17.5 Tissue Regenix Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂